arrow
S

Samra Turajlic

the royal marsden hospital nhs foundation trust
H指数:53
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

71 Integrated Spatial Multi-omics Reveals Tumour Immune Microenvironment Programmes Underlying Durable Response and Resistance to Dual ICI Therapy in ccRCC

71 整合空间多组学揭示ccRCC中持久应答和抗双ICI疗法下的肿瘤免疫微环境调控程序

2026-09-020
OAAI
2 Relationships Between Plasma KIM-1 Levels, Peripheral Immune Profiles and Disease-Free Survival Outcomes in the TransRAMPART Study

2 血浆KIM-1水平、外周免疫谱与无病生存结局之间的关系:TransRAMPART研究

2026-09-020
OAAI
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials

同步转移性肾细胞癌中双免疫检查点抑制剂的长期真实世界生存结局:对前瞻性细胞减灭性肾切除术试验设计的启示

2025-12-190
OAAI
Somatic evolution following cancer treatment in normal tissue

正常组织中癌症治疗后的体细胞进化

Nature
IF48.5
2025-12-100
OA
Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function

出版更正:TCF1和LEF1促进B-1a细胞的稳态和调控功能

Nature
IF48.5
2025-09-160
OAAI
TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function

TCF1和LEF1促进B-1a细胞的稳态和调控功能

Nature
IF48.5
2025-08-200
OA
Uveal Melanoma UK National Guidelines: 2023 Update

脉络膜黑色素瘤英国国家指南:2023年更新

2025-08-050
PREAI
Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling

全基因组规模的纠错型流式测序及其在循环游离DNA分析中的应用

2025-04-110
PRE
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions

肾细胞癌的新辅助和辅助免疫疗法:优势、劣势及未来方向

2024-09-010
OAAI
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

使用机器学习引导的信号富集技术对基于血浆的肿瘤负荷进行超灵敏监测

2024-06-144
OAAI
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors

因免疫检查点抑制剂相关毒性而接受全身皮质类固醇治疗的患者中复方新诺明诱导的皮疹发生率增加

2024-05-160
PRE
Predicting tumor evolution from digital histology using AI

使用AI从数字组织学预测肿瘤演变

2024-03-220
PRE
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

尼洛替尼治疗试剂盒驱动的晚期黑色素瘤: II期单臂NICAM试验的结果

2024-03-012
OAAI
Representative sampling of invasive breast carcinomas: Interim report from a prospective study (HOLST-F)

浸润性乳腺癌的代表性采样: 前瞻性研究的中期报告 (holst-f)

2024-02-010
PRE